Cargando…

Using Misoprostol for Primary versus Secondary Prevention of Postpartum Haemorrhage – Do Costs Matter?

BACKGROUND: Postpartum heammorrhage (PPH), defined as blood loss greater than or equal to 500 ml within 24 hours after birth, is the leading cause of maternal deaths globally and in India. Misoprostol is an important option for PPH management in setting where oxytocin (the gold standard for PPH prev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chatterjee, Susmita, Sarkar, Anupam, Rao, Krishna D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068696/ https://www.ncbi.nlm.nih.gov/pubmed/27755601 http://dx.doi.org/10.1371/journal.pone.0164718

Ejemplares similares

Misoprostol for primary versus secondary prevention of postpartum haemorrhage: a cluster‐randomised non‐inferiority community trial
por: Raghavan, S, et al.
Publicado: (2016)

Prevention of postpartum haemorrhage: cost consequences analysis of misoprostol in low-resource settings
por: Lang, Danielle L., et al.
Publicado: (2015)

Comparison effect of intravenous tranexamic acid and misoprostol for postpartum haemorrhage
por: Sahhaf, Farnaz, et al.
Publicado: (2014)

Oral misoprostol for preventing postpartum haemorrhage in home births in rural Bangladesh: how effective is it?
por: Nasreen, Hashima-E-, et al.
Publicado: (2011)

Safety and Efficacy of Misoprostol versus Oxytocin for the Prevention of Postpartum Hemorrhage
por: Rajaei, Minoo, et al.
Publicado: (2014)

Feasibility, Acceptability, and Programme Effectiveness of Misoprostol for Prevention of Postpartum Haemorrhage in Rural Bangladesh: A Quasiexperimental Study
por: Quaiyum, Abdul, et al.
Publicado: (2014)

Misoprostol for treating postpartum haemorrhage: a randomized controlled trial [ISRCTN72263357]
por: Hofmeyr, G Justus, et al.
Publicado: (2004)

Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda
por: Lubinga, Solomon J., et al.
Publicado: (2015)

Efficacy of Rectal Misoprostol for Prevention of Postpartum Hemorrhage
por: Mirteimouri, Masoumeh, et al.
Publicado: (2013)

Correction: Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda
por: Lubinga, Solomon J., et al.
Publicado: (2016)

Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial
por: Mobeen, N, et al.
Publicado: (2011)

Training Traditional Birth Attendants on the Use of Misoprostol and a Blood Measurement Tool to Prevent Postpartum Haemorrhage: Lessons Learnt from Bangladesh
por: Bell, Suzanne, et al.
Publicado: (2014)

Effectiveness and safety of misoprostol distributed to antenatal women to prevent postpartum haemorrhage after child-births: a stepped-wedge cluster-randomized trial
por: Ononge, Sam, et al.
Publicado: (2015)

Modeling maternal mortality in Bangladesh: the role of misoprostol in postpartum hemorrhage prevention
por: Prata, Ndola, et al.
Publicado: (2014)

Randomized controlled trial comparing 400μg sublingual misoprostol versus placebo for prevention of primary postpartum hemorrhage
por: Zgaya, Rym, et al.
Publicado: (2020)

Uterotonic Drugs for the Prevention of Postpartum Haemorrhage: A Cost-Effectiveness Analysis
por: Pickering, Karen, et al.
Publicado: (2018)

Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in Benin and Mali
por: Dumont, Alexandre, et al.
Publicado: (2017)

Misoprostol for Prevention of Postpartum Hemorrhage at Home Birth in Afghanistan: Program Expansion Experience
por: Haver, Jaime, et al.
Publicado: (2016)

Access to oxytocin and misoprostol for management of postpartum haemorrhage in Kenya, Uganda and Zambia: a cross-sectional assessment of availability, prices and affordability
por: Kibira, Denis, et al.
Publicado: (2021)

Influence of nursing interventions in improving midwives’ knowledge of misoprostol use in the management of postpartum haemorrhage at selected hospitals in Ondo State, Nigeria
por: Iwaola, Olufunke Mercy, et al.
Publicado: (2021)

Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage: what difference do they make?
por: León, Wilfrido, et al.
Publicado: (2012)

High fever following postpartum administration of sublingual misoprostol
por: Durocher, J, et al.
Publicado: (2010)

Postpartum Seizure and Subarachnoid Haemorrhage Secondary to Moyamoya Disease
por: Varanasi, L. Chitra, et al.
Publicado: (2019)

Implementing at-scale, community-based distribution of misoprostol tablets to mothers in the third stage of labor for the prevention of postpartum haemorrhage in Sokoto State, Nigeria: Early results and lessons learned
por: Orobaton, Nosakhare, et al.
Publicado: (2017)

The Prevention and Treatment of Postpartum Haemorrhage in Domiciliary Practice
por: McIlroy, Louise
Publicado: (1952)

Sublingual Misoprostol versus Intramuscular Oxytocin for Prevention of Postpartum Hemorrhage in Uganda: A Double-Blind Randomized Non-Inferiority Trial
por: Atukunda, Esther C., et al.
Publicado: (2014)

Foley catheter plus misoprostol versus misoprostol alone for labor induction
por: Elpo, Jhonathan Alcides, et al.
Publicado: (2023)

Misoprostol as an adjunct to oxytocin can reduce postpartum-haemorrhage: a propensity score–matched retrospective chart review in Bamenda-Cameroon, 2015–2016
por: Morfaw, Frederick, et al.
Publicado: (2019)

Intravenous tranexamic acid vs. sublingual misoprostol in high-risk women for postpartum haemorrhage following cesarean delivery; a randomised clinical trial
por: Dawoud, Mariam, et al.
Publicado: (2023)

Use of misoprostol in the treatment of postpartum hemorrhage: a pharmacoepidemiological approach
por: Koch, Daeska Marcella, et al.
Publicado: (2019)

Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date
por: Smith, Jeffrey Michael, et al.
Publicado: (2013)

Advance distribution of misoprostol for prevention of postpartum hemorrhage (PPH) at home births in two districts of Liberia
por: Smith, Jeffrey Michael, et al.
Publicado: (2014)

Misoprostol for the prevention of post-partum haemorrhage in Mozambique: an analysis of the interface between human rights, maternal health and development
por: Hobday, Karen, et al.
Publicado: (2020)

Current research on carbetocin and implications for prevention of postpartum haemorrhage
por: Theunissen, Fiona J., et al.
Publicado: (2018)

Prevention of postpartum haemorrhage: a distributional approach for analysis
por: Piaggio, Gilda, et al.
Publicado: (2018)

Management of postpartum haemorrhage
por: Bonnet, Marie Pierre, et al.
Publicado: (2016)

Management of Postpartum Haemorrhage
por: Günaydın, Berrin
Publicado: (2022)

Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in India
por: Cook, John R., et al.
Publicado: (2023)

A prospective study to compare the effectiveness of adjunctive rectal misoprostol or oxytocin titration in the prevention of primary post-partum haemorrhage in at risk patients
por: Muhammad, Rafat, et al.
Publicado: (2019)

Comparison of Clinical Efficacy and Safety between Misoprostol and Oxytocin in the Prevention of Postpartum Hemorrhage: A Meta-Analysis
por: Xu, Renmei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rt4qmi4epvgtp538a122ltt5to